↓ Skip to main content

The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic

Overview of attention for article published in Frontiers in Molecular Biosciences, December 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
12 X users

Readers on

mendeley
72 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
Published in
Frontiers in Molecular Biosciences, December 2020
DOI 10.3389/fmolb.2020.610132
Pubmed ID
Authors

Ludwig Aigner, Frank Pietrantonio, Diana Marisa Bessa de Sousa, Johanna Michael, Daniela Schuster, Herbert Anton Reitsamer, Horst Zerbe, Michael Studnicka

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 11%
Student > Doctoral Student 7 10%
Student > Bachelor 6 8%
Other 5 7%
Student > Ph. D. Student 5 7%
Other 12 17%
Unknown 29 40%
Readers by discipline Count As %
Medicine and Dentistry 15 21%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Biochemistry, Genetics and Molecular Biology 4 6%
Nursing and Health Professions 3 4%
Agricultural and Biological Sciences 3 4%
Other 14 19%
Unknown 27 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2022.
All research outputs
#3,881,405
of 23,342,232 outputs
Outputs from Frontiers in Molecular Biosciences
#336
of 4,015 outputs
Outputs of similar age
#96,027
of 475,154 outputs
Outputs of similar age from Frontiers in Molecular Biosciences
#23
of 192 outputs
Altmetric has tracked 23,342,232 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,015 research outputs from this source. They receive a mean Attention Score of 3.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 475,154 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 192 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.